Sowell Financial Services LLC Gilead Sciences, Inc. Transaction History

Sowell Financial Services LLC

  • $2.1 Billion
  • Q3 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$63.15 - $72.88 $29,996 - $34,618
-475 Reduced 3.7%
12,359 $847,000
Q1 2024

May 03, 2024
BUY
$71.58 - $87.29 $40,156 - $48,969
561 Added 4.57%
12,834 $940,000
Q4 2023

Jan 24, 2024
SELL
$73.27 - $83.09 $451,856 - $512,416
-6,167 Reduced 33.44%
12,273 $994,000
Q3 2023

Nov 08, 2023
BUY
$73.94 - $80.67 $278,827 - $304,206
3,771 Added 25.71%
18,440 $1.38 Million
Q2 2023

Aug 14, 2023
BUY
$76.01 - $86.7 $281,693 - $321,310
3,706 Added 33.8%
14,669 $1.13 Million
Q1 2023

May 12, 2023
SELL
$77.31 - $88.08 $563,126 - $641,574
-7,284 Reduced 39.92%
10,963 $909,000
Q4 2022

Feb 09, 2023
BUY
$62.32 - $89.47 $71,792 - $103,069
1,152 Added 6.74%
18,247 $1.57 Million
Q3 2022

Nov 15, 2022
SELL
$59.54 - $68.01 $565,749 - $646,231
-9,502 Reduced 35.73%
17,095 $1.06 Million
Q2 2022

Aug 15, 2022
BUY
$57.72 - $65.01 $1.54 Million - $1.73 Million
26,597 New
26,597 $1.64 Million
Q1 2022

May 13, 2022
SELL
$57.92 - $72.58 $776,417 - $972,934
-13,405 Closed
0 $0
Q4 2021

Feb 09, 2022
BUY
$64.88 - $73.64 $192,239 - $218,195
2,963 Added 28.38%
13,405 $973,000
Q3 2021

Nov 04, 2021
BUY
$67.69 - $73.03 $706,818 - $762,579
10,442 New
10,442 $729,000
Q2 2021

Aug 05, 2021
SELL
$63.47 - $69.35 $1.48 Million - $1.61 Million
-23,275 Closed
0 $0
Q1 2021

May 07, 2021
BUY
$60.0 - $68.46 $565,560 - $645,303
9,426 Added 68.06%
23,275 $1.55 Million
Q4 2020

Jan 13, 2021
SELL
$56.65 - $64.55 $328,796 - $374,648
-5,804 Reduced 29.53%
13,849 $807,000
Q3 2020

Nov 12, 2020
BUY
$62.1 - $78.08 $474,195 - $596,218
7,636 Added 63.54%
19,653 $1.24 Million
Q2 2020

Aug 13, 2020
BUY
$72.34 - $84.0 $21,702 - $25,200
300 Added 2.56%
12,017 $925,000
Q1 2020

May 12, 2020
BUY
$62.63 - $80.22 $49,289 - $63,133
787 Added 7.2%
11,717 $876,000
Q4 2019

Feb 07, 2020
SELL
$61.62 - $67.78 $235,573 - $259,122
-3,823 Reduced 25.91%
10,930 $710,000
Q3 2019

Nov 14, 2019
BUY
$62.51 - $69.0 $121,269 - $133,860
1,940 Added 15.14%
14,753 $935,000
Q1 2019

May 15, 2019
BUY
$62.53 - $70.05 $43,583 - $48,824
697 Added 5.75%
12,813 $0
Q4 2018

Mar 05, 2019
BUY
$60.54 - $79.0 $222,242 - $290,009
3,671 Added 43.47%
12,116 $758,000
Q3 2018

Nov 13, 2018
BUY
$71.28 - $78.92 $48,755 - $53,981
684 Added 8.81%
8,445 $652,000
Q2 2018

Aug 14, 2018
BUY
$64.88 - $75.68 $58,262 - $67,960
898 Added 13.08%
7,761 $599,000
Q1 2018

May 10, 2018
BUY
$72.84 - $88.8 $162,797 - $198,468
2,235 Added 48.29%
6,863 $459,000
Q4 2017

Jan 29, 2018
BUY
$71.15 - $83.52 $25,258 - $29,649
355 Added 8.31%
4,628 $376,000
Q3 2017

Nov 07, 2017
BUY
$72.11 - $85.47 $308,126 - $365,213
4,273
4,273 $320,000

Others Institutions Holding GILD

# of Institutions
1,927
Shares Held
994M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email